SC
REGN icon

Schubert & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Schubert & Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23
Closed -$18.9K – 1176
2023
Q1 		$18.9K Buy
23
+1
+5% +$754 0.02% 136
2022
Q4 		$15.9K Buy
22
+4
+22% +$2.95K 0.01% 138
2022
Q3 		$12K Buy
18
+2
+13% +$1.26K 0.01% 169
2022
Q2 		$9K Buy
16
+7
+78% +$4.55K 0.01% 196
2022
Q1 		$6K Hold
9
– – 0.01% 153
2021
Q4 		$6K Buy
+9
New +$5.53K 0.01% 129

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return